Article
Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines.
PharmacoEconomics - 1 Jan 2009
Siebert Uwe, Sroczynski Gaby, Aidelsburger Pamela, Rossol Siegbert, Wasem Jürgen, Manns Michael P, McHutchison John G, Wong John B
Abstract excerpt
BACKGROUND: Recently developed German guidelines for antiviral treatment in patients with chronic hepatitis C recommend basing drug dosage, intended treatment duration and early stopping rules on the genotype of the hepatitis C virus and early viral responses to treatment. OBJECTIVES: To evaluate effectiveness and cost effectiveness of different antiviral treatment strategies including the German guidelines, for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.